|
|
Blood, 1 September 2004, Vol. 104, No. 5, pp. 1519-1525.
Prepublished online as a Blood First Edition Paper on May 20, 2004; DOI 10.1182/blood-2003-11-3872.
Previous Article | Next Article 
Submitted November 13, 2003
Accepted May 4, 2004
Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis
Anita C Chua, John K Olynyk, Peter L Leedman, and Debbie Trinder*
Department of Medicine, School of Medicine and Pharmacology, Fremantle Hospital, The University of Western Australia, Fremantle, Western Australia, Australia
Department of Medicine, School of Medicine and Pharmacology, Fremantle Hospital, The University of Western Australia, Fremantle, Western Australia, Australia; Western Australian Institute for Medical Research, Nedlands, Western Australia, Australia
Laboratory of Cancer Medicine, School of Medicine and Pharmacology, Western Australian Institute for Medical Research, Royal Perth Hospital,, The University of Western Australia, Perth, Western Australia, Australia
* Corresponding author; email: dtrinder{at}cyllene.uwa.edu.au.
Hereditary hemochromatosis (HH) is an iron overload disorder caused by a C282Y mutation in the HFE gene. In HH, plasma nontransferrin-bound iron (NTBI) levels are increased and NTBI is bound mainly by citrate. The aim of this study was to examine the importance of NTBI in the pathogenesis of hepatic iron loading in Hfe knockout mice. Plasma NTBI levels were increased 2.5-fold in Hfe knockout mice compared with control mice. Total ferric citrate uptake by hepatocytes isolated from Hfe knockout mice (34.1±2.8 pmol Fe/mg protein/min) increased by two-fold compared with control mice (17.8±2.7 pmol Fe/mg protein/min;p<0.001; mean±SEM; n=7). Ferrous ion chelators, bathophenanthroline disulfonate and 2',2-bipyridine inhibited ferric citrate uptake by hepatocytes from both mouse types. Divalent metal ions inhibited ferric citrate uptake by hepatocytes, as did diferric transferrin. Divalent metal transporter 1 (DMT1) mRNA and protein expression was increased approximately two-fold by hepatocytes from Hfe knockout mice. We conclude that NTBI uptake by hepatocytes from Hfe knockout mice contributed to hepatic iron loading. Ferric ion was reduced to ferrous ion and taken up by hepatocytes by a pathway shared with diferric transferrin. Inhibition of uptake by divalent metals and up-regulation of DMT1 expression suggested that NTBI uptake was mediated by DMT1.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. E. Herbison, K. Thorstensen, A. C. G. Chua, R. M. Graham, P. Leedman, J. K. Olynyk, and D. Trinder
The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells
Am J Physiol Cell Physiol,
December 1, 2009;
297(6):
C1567 - C1575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gao, N. Zhao, M. D. Knutson, and C. A. Enns
The Hereditary Hemochromatosis Protein, HFE, Inhibits Iron Uptake via Down-regulation of Zip14 in HepG2 Cells
J. Biol. Chem.,
August 1, 2008;
283(31):
21462 - 21468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Drake, E. H. Morgan, C. E. Herbison, R. Delima, R. M. Graham, A. C. G. Chua, P. J. Leedman, R. E. Fleming, B. R. Bacon, J. K. Olynyk, et al.
Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3
Am J Physiol Gastrointest Liver Physiol,
January 1, 2007;
292(1):
G323 - G328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chaudhury, J. Kim, S. Mehnaz, M. A. Wani, T. M. Oberyszyn, C. L. Bronson, S. Mohanty, W. L. Hayton, J. M. Robinson, and C. L. Anderson
Accelerated Transferrin Degradation in HFE-Deficient Mice Is Associated with Increased Transferrin Saturation
J. Nutr.,
December 1, 2006;
136(12):
2993 - 2998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Liuzzi, F. Aydemir, H. Nam, M. D. Knutson, and R. J. Cousins
Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells
PNAS,
September 12, 2006;
103(37):
13612 - 13617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Ohgami, D. R. Campagna, A. McDonald, and M. D. Fleming
The Steap proteins are metalloreductases
Blood,
August 15, 2006;
108(4):
1388 - 1394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. T. Mak, J. J. Chmielinska, L. Nedelec, A. Torres, and W. B. Weglicki
D-Propranolol Attenuates Lysosomal Iron Accumulation and Oxidative Injury in Endothelial Cells
J. Pharmacol. Exp. Ther.,
May 1, 2006;
317(2):
522 - 528.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|